Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Antacids Industry?

In recent times, there has been significant growth in the market size of oxycodone drugs. The market which was valued at $5.62 billion in 2024 is projected to grow to $5.98 billion in 2025 with a compound annual growth rate (CAGR) of 6.4%. This growth during the historic period can be traced back to the aggressive strategy deployed in marketing oxycontin. It was primarily promoted for managing chronic non-cancerous pain and cancer. As a result, there was an increase in prescriptions for oxycontin relating to non-cancer pain, fueling the demand for these drugs. Also, synthetic opiates like oxycodone gained considerable market presence following the second world war.

It is anticipated that the oxycodone drugs market will experience robust growth in the forthcoming years. The market is projected to escalate to $7.66 billion by 2029, with a compound annual growth rate (CAGR) of 6.4%. This surge during the forecast period can be associated with the escalating occurrence of chronic pain, the increase in surgical procedures, continual enhancements in the product pipeline expected to stimulate growth, improvements in medication delivery systems, and an increasing elderly population across the globe facing frequent chronic pain. Prime trends for the upcoming period encompass heightened demand for abuse-deterrent formulations (ADFS), the emergence of innovative delivery systems, the escalating utilization of combined therapies, and technological progress in production.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

What Forces Are Driving The Growth Of The Antacids Industry?

The amplification of acidity caused by unsound lifestyle choices plays a crucial role in driving the expansion of the antacids market. These choices include sedentary jobs, lack of quality sleep, and inconsistent eating habits that increase stomach acidity leading to gastroesophageal reflux disease. It’s been reported by the American College of Gastroenterology that approximately 60 million Americans grapple with gastroesophageal reflux disease, which in turn fuels the need for antacids.

The oxycodone drugs market covered in this report is segmented –

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone

2) By Dosage Form: Tablets, Capsules, Injections

3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution

2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

Which Trends Are Redefining The Future Landscape Of The Antacids Industry?

Leading firms in the oxycodone drug market are concentrating on creating novel medications like oxycodone immediate-release (IR) tablets, with the aim of minimizing drug misuse via injection or nasal intake. Oxycodone immediate-release (IR) tablets, a variation of the opioid painkiller oxycodone, are specifically designed for immediate relief from pain. For example, Protega Pharmaceuticals LLC, an American pharmaceutical company, introduced RoxyBond, an oxycodone immediate-release (IR) tablet, to the U.S. market in July 2022. The U.S. Food and Drug Administration (FDA) approved RoxyBond as an opioid receptor for managing intense pain when other alternatives are inadequate. It is manufactured using sophisticated technology to prevent misappropriation and misuse, making it hard to alter either physically or chemically.

Who Are The Primary Players Operating Across The Global Antacids Market?

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Region Offers The Most Growth Potential For The Antacids Market Through 2029?

North America was the largest region in the oxycodone drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15886&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model